Compare MAIN & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | MAIN | BIRK |
|---|---|---|
| Founded | 2007 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 6.1B |
| IPO Year | 2013 | 2023 |
| Metric | MAIN | BIRK |
|---|---|---|
| Price | $55.13 | $35.23 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 14 |
| Target Price | $61.57 | ★ $62.69 |
| AVG Volume (30 Days) | 847.1K | ★ 2.2M |
| Earning Date | 05-07-2026 | 02-12-2026 |
| Dividend Yield | ★ 7.85% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.95 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.27 | $13.71 |
| Revenue Next Year | $5.14 | $14.21 |
| P/E Ratio | ★ $13.85 | $17.48 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $47.00 | $33.06 |
| 52 Week High | $67.77 | $57.39 |
| Indicator | MAIN | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 39.61 | 39.48 |
| Support Level | $55.06 | N/A |
| Resistance Level | $59.24 | $42.19 |
| Average True Range (ATR) | 1.35 | 1.48 |
| MACD | -0.00 | -0.44 |
| Stochastic Oscillator | 21.58 | 24.52 |
Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancing, and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants, and other securities of the lower middle market and middle market companies based in the United States. Business functioned through the U.S. region and it derives the majority of its income from the source of fees, commission, and interest.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.